G Pitsiou, A Paspala, V Bagalas, A K Boutou, I Stanopoulos. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Administration, InhalationCritical CareDiuretics/therapeutic useFurosemide/therapeutic useHeart Failure/drug therapyHeart Failure/etiologyHumansHydrazones/therapeutic useHypertension, Pulmonary/complicationsIloprost/administration & dosageIloprost/therapeutic useMaleMiddle AgedPyridazines/therapeutic useSimendanThromboembolism/complicationsVasodilator Agents/administration & dosageVasodilator Agents/therapeutic useVentricular Dysfunction, Right/drug therapy
Substances: See more » DiureticsHydrazonesPyridazinesVasodilator AgentsSimendanFurosemideIloprost
Year: 2013 PMID: 23808522
Source DB: PubMed Journal: Anaesth Intensive Care ISSN: 0310-057X Impact factor: 1.669